Cargando…
Serum neurofilament light chain is increased in hereditary spastic paraplegias
Blood biomarkers are still largely missing in hereditary spastic paraplegias (HSPs). We here explored Neurofilament light chain (NfL) as a biomarker in HSP. Serum NfL was assessed in 96 HSP (63 genetically confirmed), 96 healthy control, and 33 ALS subjects by single molecule array (Simoa). Compared...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043776/ https://www.ncbi.nlm.nih.gov/pubmed/30009206 http://dx.doi.org/10.1002/acn3.583 |
_version_ | 1783339353463848960 |
---|---|
author | Wilke, Carlo Rattay, Tim W. Hengel, Holger Zimmermann, Milan Brockmann, Kathrin Schöls, Ludger Kuhle, Jens Schüle, Rebecca Synofzik, Matthis |
author_facet | Wilke, Carlo Rattay, Tim W. Hengel, Holger Zimmermann, Milan Brockmann, Kathrin Schöls, Ludger Kuhle, Jens Schüle, Rebecca Synofzik, Matthis |
author_sort | Wilke, Carlo |
collection | PubMed |
description | Blood biomarkers are still largely missing in hereditary spastic paraplegias (HSPs). We here explored Neurofilament light chain (NfL) as a biomarker in HSP. Serum NfL was assessed in 96 HSP (63 genetically confirmed), 96 healthy control, and 33 ALS subjects by single molecule array (Simoa). Compared to controls, NfL was increased in HSP (P < 0.001), correlating with cross‐sectional disease progression (ρ = 0.28). Levels were lower than in ALS (P < 0.001), allowing to differentiate HSP from ALS (AUC = 0.91). Serum NfL might serve as a biomarker in HSP indicating neuronal damage and, if confirmed longitudinally, disease progression. It might also support differentiating HSP from ALS. |
format | Online Article Text |
id | pubmed-6043776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60437762018-07-15 Serum neurofilament light chain is increased in hereditary spastic paraplegias Wilke, Carlo Rattay, Tim W. Hengel, Holger Zimmermann, Milan Brockmann, Kathrin Schöls, Ludger Kuhle, Jens Schüle, Rebecca Synofzik, Matthis Ann Clin Transl Neurol Brief Communications Blood biomarkers are still largely missing in hereditary spastic paraplegias (HSPs). We here explored Neurofilament light chain (NfL) as a biomarker in HSP. Serum NfL was assessed in 96 HSP (63 genetically confirmed), 96 healthy control, and 33 ALS subjects by single molecule array (Simoa). Compared to controls, NfL was increased in HSP (P < 0.001), correlating with cross‐sectional disease progression (ρ = 0.28). Levels were lower than in ALS (P < 0.001), allowing to differentiate HSP from ALS (AUC = 0.91). Serum NfL might serve as a biomarker in HSP indicating neuronal damage and, if confirmed longitudinally, disease progression. It might also support differentiating HSP from ALS. John Wiley and Sons Inc. 2018-05-21 /pmc/articles/PMC6043776/ /pubmed/30009206 http://dx.doi.org/10.1002/acn3.583 Text en © 2018 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Communications Wilke, Carlo Rattay, Tim W. Hengel, Holger Zimmermann, Milan Brockmann, Kathrin Schöls, Ludger Kuhle, Jens Schüle, Rebecca Synofzik, Matthis Serum neurofilament light chain is increased in hereditary spastic paraplegias |
title | Serum neurofilament light chain is increased in hereditary spastic paraplegias |
title_full | Serum neurofilament light chain is increased in hereditary spastic paraplegias |
title_fullStr | Serum neurofilament light chain is increased in hereditary spastic paraplegias |
title_full_unstemmed | Serum neurofilament light chain is increased in hereditary spastic paraplegias |
title_short | Serum neurofilament light chain is increased in hereditary spastic paraplegias |
title_sort | serum neurofilament light chain is increased in hereditary spastic paraplegias |
topic | Brief Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043776/ https://www.ncbi.nlm.nih.gov/pubmed/30009206 http://dx.doi.org/10.1002/acn3.583 |
work_keys_str_mv | AT wilkecarlo serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT rattaytimw serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT hengelholger serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT zimmermannmilan serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT brockmannkathrin serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT scholsludger serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT kuhlejens serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT schulerebecca serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias AT synofzikmatthis serumneurofilamentlightchainisincreasedinhereditaryspasticparaplegias |